Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guérin

Competing Interest Statement

J.C.C is co-founder of PrecisionProfile. All other contributing authors have no conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter in the manuscript.

Funding Statement

This work was generously supported by MRACE Grant no.107477 (TZ), the Anschutz Foundation (JCC, DT), FICAN Cancer Researcher by the Finnish Cancer Institute (TDL), and in part from CA075115 (DT).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB approval was obtained from the Erasmus MC Medical Research Committee (MEC-2018-1097).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes